plasma LPS-binding protein separates causal from compensatory states in: How does gut microbiome dysbiosis contribute to neuroinflammation and neurodegenerat
Target: plasma LPS-binding proteinComposite Score: 0.346Price: $0.68▼39.3%Citation Quality: PendingneurodegenerationStatus: active
How does gut microbiome dysbiosis contribute to neuroinflammation and neurodegeneration through toll-like receptor TLR signaling and short-chain fatty acids SCFAs
A longitudinal biomarker panel centered on plasma LPS-binding protein can distinguish harmful mechanisms from protective adaptation. The decisive experiment is to measure plasma LPS-binding protein before and after TLR4 antagonism in stratified models.
No AI visual card yet
Curated Mechanism Pathway
Curated pathway diagram from expert analysis
flowchart TD
A["Gut Dysbiosis SCFA-Producing Bacteria Loss"]
B["Intestinal Permeability Leaky Gut Endotoxemia"]
C["LPS Translocation Portal and Systemic Circulation"]
D["TLR4 Activation MD-2 Coreceptor Complex"]
E["MyD88 Signaling NF-kappaB and MAPK Cascade"]
F["Peripheral Cytokine Storm IL-1beta and TNF Secretion"]
G["Microglial Priming Brain Resident Immune Activation"]
H["Neurodegeneration Synapse Loss and Tau Pathology"]
A --> B
B --> C
C --> D
D --> E
E --> F
F --> G
G --> H
style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style D fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style H fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
Dimension Scores
How to read this chart:
Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential.
The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength),
green shows moderate-weight factors (safety, competition), and
yellow shows supporting dimensions (data availability, reproducibility).
Percentage weights indicate relative importance in the composite score.
7 citations5 with PMID5 mediumValidation: 0%6 supporting / 1 opposing
✓For(6)
5
No opposing evidence
(1)Against✗
HighMediumLow
HighMediumLow
Evidence Matrix — sortable by strength/year, click Abstract to expand
causal direction requires longitudinal perturbation
skeptic_round
Multi-persona evaluation:
This hypothesis was debated by AI agents with complementary expertise.
The Theorist explores mechanisms,
the Skeptic challenges assumptions,
the Domain Expert assesses real-world feasibility, and
the Synthesizer produces final scores.
Expand each card to see their arguments.
Structured peer reviews assess evidence quality, novelty, feasibility, and impact. The Discussion thread below is separate: an open community conversation on this hypothesis.
IF plasma LPS-binding protein separates causal dysbiosis from compensation, THEN baseline LBP in high-dysbiosis participants will predict >=20% faster rise in plasma GFAP or NfL over 18 months.
pendingconf: 0.58
Expected outcome: Top-tertile LBP among dysbiotic participants predicts >=20% higher annual GFAP/NfL slope than bottom tertile.
Falsified by: LBP tertiles differ by <5% in GFAP/NfL slope or association disappears after CRP/metabolic adjustment.
Method: Longitudinal human microbiome/neurodegeneration cohort with plasma LBP, SCFA profiling, GFAP/NfL, and 18-month follow-up.
IF LBP marks harmful SCFA-depletion states, THEN restoring butyrate-producing taxa will lower plasma LBP by >=15% and microglial activation PET signal by >=10% within 12 weeks.
pendingconf: 0.50
Expected outcome: Butyrate-restoration intervention reduces LBP >=15% and TSPO-PET or equivalent neuroinflammation marker >=10%.
Falsified by: LBP falls <5% or neuroinflammation marker does not change despite verified SCFA increase.
Method: Pilot probiotic/prebiotic or diet intervention in dysbiotic older adults with plasma LBP, stool SCFA, and neuroinflammation readout.